EUROPIUM(II) SELENIDE: Crystal Structure
EUROPIUM(II) SELENIDE consists of the elemental system Eu-Se forming black (or brown) cubic conjugated crystals with the space group Fm3m, cell parameter a = 0.6185 nm and Z = 4.
Apr 2，2024 API
Thorium Boride Crystal Structure
Thorium Boride is hard, high-melting materials with metal-like conductivity. It is stable to nonoxidizing acids but break down in strong oxidizing agents and strong alkalis.
Apr 2，2024 Inorganic chemistry
Ibrutinib: Uses, Mechanism of action and Side effects
Ibrutinib is an oral, potent, selective and irreversible small molecule inhibitor of Btk. It is a prescription drug with the trade name IMBRUVICA?.
Apr 2，2024 Drugs
Crystal Structures of Molybdenum Nitride(Mo3N5) with Anisotropic Compressibility
This article will briefly introduce a research paper, which synthesized Mo3N5 at above 45 GPa via a nitridation reaction of molybdenum.
Apr 2，2024 Inorganic chemistry
What is the use and crystal structure of chromium carbide?
Chromium carbide exists as a gray solid at standard conditions. It is tough and corrosion-resistant.
Apr 2，2024 Inorganic chemistry
Cinacalcet: Application, Mechanism of action and Side effects
Cinacalcet is an orthosteric modulator of the calcium-sensitive receptor (CaSR) and acts as a calcimimetic.
Apr 2，2024 Drugs
Tantalum disilicide:Crystal Structure,Uses,Hazards
Tantalum disilicide (TaSi2) has excellent properties such as high melting point, low resistivity, corrosion resistance, high-temperature oxidation resistance, and good compatibility with silicon, carb
Apr 2，2024 Inorganic chemistry
Mechanisms of resistance to ABT-199 in leukemia and lymphoma cell lines
ABT-199 (Venetoclax) is a potent, orally bioavailable, selective inhibitor of BCL-2. It is approved for the treatment of first-line and relapsed/refractory chronic lymphocytic leukaemia (CLL) and acut
Apr 2，2024 Inhibitors
When was sorafenib tosylate approved by the FDA?
On December 20, 2005, the Food and Drug Administration (FDA) granted regular marketing approval for sorafenib tosylate 200-mg tablets.
Apr 2，2024 API
What is the side effect of Nintedanib (BIBF-1120)
Nintedanib (BIBF-1120) is an orally administered intracellular tyrosine kinase inhibitor (TKI) initially developed as an antitumor agent.
Apr 2，2024 API